Kentford, Suffolk, UK: Pharmaceutical services business Biotec Services International has launched a dedicated new storage and operational facility along with upgraded and dedicated storage areas for advanced therapeutic medicinal products and Schedule II to V Controlled Substances.
The expansion will result in a 200% increase in temperature controlled storage capacity, says Biotec. It offers GMP storage on a dual site operation with a temperature range from controlled ambient down to minus 196C. The purpose-built split site is licensed by the MHRA for investigational, commercial and named patient medicinal products.
Led by chief executive Keren Winmill, Biotec was established in 1997 and is now a global provider of clinical trial services including import, certification, labelling, assembly, storage and distribution. The company works with a global client base to conduct trials from Phase I to Phase IV.
Keren Winmill of Biotec says: “The development of our temperature controlled storage facilities is in line with client demand. Be it one-off samples or commercial supplies, we hope that clients will benefit from the new facilities. Of course, we are not only qualified to collect, store and deliver clinical trial and pharmaceutical products we can also handle patient samples.
“The dual site storage arrangements give clients the opportunity to minimise risk and allows us to focus on developing both our clinical trial business and commercial/ATMP materials by streamlining processes accordingly,” he says.
